3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Motor Activity
3
Sleep Wake Disorders
2
Overweight
2
Ovarian Neoplasms
2
Obesity
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Urinary Bladder Neoplasms
1
Thyroid Cancer, Papillary
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Locally Advanced Head and Neck Squamous Cell Carcinoma
1
Kidney Neoplasms
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Head and Neck Carcinoma
1
Fatigue
1
Endometrial Neoplasms
1
Depressive Disorder
1
Depression
1
Castration-Resistant Prostate Cancer (CRPC)
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breast Carcinoma In Situ
1
Anxiety Disorders
1
Interventions
Rituximab
28
acalabrutinib
15
ibrutinib
14
Cyclophosphamide
13
venetoclax
10
Lenalidomide
10
CT-P10
10
zanubrutinib
9
Magnetic Resonance Spectroscopy
8
obinutuzumab
7
fludarabine
7
Specimen Handling
7
Cytarabine
7
Bendamustine Hydrochloride
7
pirtobrutinib
6
Peripheral Blood Stem Cell Transplantation
6
Biopsy
6
glofitamab
5
fludarabine phosphate
5
Whole-Body Irradiation
5
Cyclosporine
5
brexucabtagene autoleucel
4
Mycophenolic Acid
4
Vincristine
3
Stem Cell Transplantation
3
Sirolimus
3
Methotrexate
3
Etoposide
3
Doxorubicin
3
Cyclosporins
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Mantle-Cell
×
Counseling
×
90 days
×
Clear all
No trials found.